Seeking Alpha

Aurelius to buy Scholl from Reckitt Benckiser

  • German private equity firm Aurelius has agreed to buy Reckitt Benckiser's (OTCPK:RBGLY) Scholl shoe business. The company is expecting the brand to expand internationally and maintain growth.
  • Aurelius will acquire the international rights to the business, except for North and South America, which will go to Bayer (OTCPK:BAYRY) as part of its $14B purchase of Merck (NYSE:MRK).
  • The deal is expected to close in the third quarter of 2014.
Comments (1)
  • biochemist
    , contributor
    Comments (551) | Send Message
    That should read "as part of its $14B purchase of Merck's consumer business".
    21 Jul 2014, 02:13 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs